Symetis SA is a Switzerland-based company, which develops invasive transcatheter heart valve implantation devices to treat valvular heart diseases. The Company's products, ACURATE TA and ACURATE neo and their delivery systems are based on proprietary design and delivery technologies. Its Symetis' Acurate Aortic Valve Replacement System offers an invasive solution for patients suffering from aortic valve stenosis. The Company provides Transcatheter aortic valve implantation (TAVI), which performs via a retrograde or antegrade approach and allows the valve delivery system through the stenotic aortic annulus via the femoral or subclavian arteries. The Company operates manufacturing sites in Ecublens, Switzerland and Belo Horizonte, Brazil; and its products are sold in the key markets oin Europe and in other markets. The Company receives funding from Endevour Vision SA.
SYMETIS SA 
